Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats
- 197 Downloads
The selective serotonin uptake inhibitor fluoxetine (10mg/kg i.p.) increased tissue levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethylene glycol sulfate (MHPG-SO4) in rat hypothalamus, indicating an increased release of norepinephrine. Microdialysis studies in conscious rats showed that fluoxetine (10 mg/kg i.p.) increased extracellular concentrations of norepinephrine as well as serotonin in the hypothalamus. In contrast, desipramine (10mg/kg i.p.) increased extracellular concentration of norepinephrine but not serotonin in the hypothalamus. Consistent with its mechanism of being a selective serotonin uptake inhibitor, local perfusion of fluoxetine (10μM) caused a 7-fold increase in hypothalamic extracellular serotonin and a small non-significant increase in extracellular norepinephrine. The subsequent systemic injection of fluoxetine (10mg/kg s.c.) after local perfusion caused a 3-fold increase in extracellular norepinephrine, indicating that fluoxetine's action leading to an increase in extracellular norepinephrine was not occurring in the terminal areas of the hypothalamus but elsewhere in the brain, possibly cell bodies in the locus coeruleus.
KeywordsFluoxetine rat hypothalamus norepinephrine microdialysis brain MHPG desipramine DMI HPLC-EC
Unable to display preview. Download preview PDF.
- Clement HW, Gemsa D, Wesmann W (1992) Serotonin-norepinephrine interactions: a voltammetric study on the effect of serotonin receptor stimulation followed in the N raphe dorsalis and the locus coeruleus of the rat. J Neural Transm [GenSect] 88: 11–23Google Scholar
- Gariepy KC, Bailey B, Yu J, Maher T, Ackworth IN (1994) Simultaneous determination of norepinephrine, dopamine, and serotonin in hippocampal microdialysis samples using normal bore high performance liquid chromatography: effects of dopamine receptor agonist stimulation and euthanasia. J Liquid Chromatogr 17: 1541–1556Google Scholar
- Mayle DA, Robertson DW, Wong DT (1991) Elevation of catecholaminergic metabolite levels in the rat hypothalamus by an agonist of serotonin 1C/2 receptors, MK212 (6-chloro-2-(l-piperazinyl) pyrazine). Neurosci Abstr 17: 407Google Scholar
- McRae-Degueurce A, Dennis T, Leger L, Scatton B (1985) Regulation of noradrenergic neuronal activity in the rat locus coeruleus by serotonergic afferents. Physiol Psychol 13: 188–196Google Scholar
- Paez X, Leibowitz S (1993) Changes in extracellular PVN monoamines and macronutrient intake after idazoxan or fluoxetine injection. Pharm Biochem Behav 46: 933–941Google Scholar
- Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego CAGoogle Scholar
- Perry KW, Fuller RW (1991) Serotonergic drugs increase MHPG-SO4 in rat hypothalamus. Neurosci Abstr 17: 1178Google Scholar
- Scatton B, Claustre Y, Graham D, Dennis T, Serrano A, Arbilla S, Pimoule C, Schoemaker H, Bigg D, Langer SZ (1988) SL 81 0385: a novel selective and potent serotonin uptake inhibitor. Drug Dev Res 12: 29–40Google Scholar
- Weissmann-Nanopoulos D, Mach E, Magre J, Demassey Y, Pujo J (1985) Evidence for the localization of 5HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 7: 1061–1072Google Scholar